![](/img/cover-not-exists.png)
Characterization of MK-4166, a clinical agonistic antibody that targets human GITR and inhibits the generation and suppressive effects of T regulatory cells
Sukumar, Selvakumar, Wilson, Douglas C, Yu, Ying, Wong, Jerelyn, Naravula, Saraswathi, Ermakov, Grigori, Riener, Romina, Bhagwat, Bhagyashree, Necheva, Antoaneta S, Grein, Jeff, Churakova, Tatyana, MaLanguage:
english
Journal:
Cancer Research
DOI:
10.1158/0008-5472.CAN-16-1439
Date:
June, 2017
File:
PDF, 6.31 MB
english, 2017